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The stratum corneum (SC) matures during late gestation
in man and other mammals. Using the fetal rat as an
experimental model, we have previously shown that
glucocorticoids given in pharmacologic doses accelerate
fetal SC maturation and barrier formation. To determine
whether glucocorticoids are required for normal SC
maturation, we examined the epidermal morphology of
glucocorticoid-deficient (C-) murine pups, derived from
matings of mice homozygous for null mutations of the
corticotropin-releasing hormone alleles. In control pups
on day 17.5 of gestation (term is 19.5 d), a multilayered SC
was present and neutral lipid deposition in a membrane
pattern was observed using Nile red fluorescence histo-
chemistry. Ultrastructurally, mature lamellar unit struc-
tures predominate in the SC intercellular domains. In
contrast, in C-pups only a single layer of SC was evident
on day 17.5, and secreted lamellar material was not
The stratum corneum (SC) matures during late gestation,such that newborns at term have a competent barrier totransepidermal water loss (Cartlidge and Rutter, 1992).Rodents provide a convenient model to study theontogenesis of the epidermal barrier (Aszterbaum et al,
1992). In the fetal rat, the permeability barrier forms on day 20 of
gestation, such that pups on day 19 have no measurable barrier to
water loss, whereas by day 21 all pups exhibit competent barriers (term
is 22 d). Certain hormones, notably glucocorticoids, thyroid hormone,
and estrogens, when administered maternally in pharmacologic doses,
accelerate formation of the fetal epidermal barrier, whereas androgens
delay barrier formation (Aszterbaum et al, 1993; Hanley et al, 1996a,
b). Yet, whether physiologic quantities of these hormones play a role
in epidermal barrier formation is unclear, because epidermal barrier
formation proceeds normally in vitro in hormone- and serum-free
medium in skin explants taken from fetal rats of gestational age 17 d
(Hanley et al, 1996a). Furthermore, mice made genetically hypothyroid
due to a mutation in the TSH receptor, leading to markedly reduced
thyroid hormone production, while displaying delayed epidermal
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organized into mature lamellar structures. Furthermore,
the expression of structural proteins necessary for corni-
fied envelope formation, involucrin, loricrin, and filag-
grin, and the activity of the lipid synthetic enzymes
b-glucocerebrosidase and steroid sulfatase, markers of
barrier maturation, were reduced in day 17.5 C-pups.
C-pups derived from pregnancies supplemented with
physiologic amounts of cortisone, however, display
normal SC ultrastructure on day 17.5 of gestation.
Furthermore, at birth, both control and C-pups exhibit
a multilayered SC replete with mature lamellar membrane
structures. These data demonstrate that fetal gluco-
corticoid deficiency delays SC maturation, and suggests
that normal levels of glucocorticoids are not absolutely
required for SC development. Key words: epidermal perme-
ability barrier/fetal skin/skin development. J Invest Dermatol
111:440–444, 1998
development during late gestation, exhibit normal SC at birth (Hanley
et al, 1997a). Thus exogenous hormones may not be essential for
epidermal maturation.
To examine the role of glucocorticoids in normal SC morphogenesis,
we have examined a murine model of severe fetal glucocorticoid
deficiency obtained through homozygous matings of transgenic mice
bearing null alleles for the corticotropin-releasing hormone (CRH)
gene (Muglia et al, 1995). These pups are both deficient in their own
ability to generate corticosteroid and are deprived of the normal
maternal milieu of corticosteroid during gestation. Although viable at
birth, they die within 12 h of life from pulmonary insufficiency, which
is prevented by prenatal glucocorticoid therapy (Muglia et al, 1995).
Here we report that the development of a multilayered SC and
formation of mature lamellar unit structures in the SC interstices is
retarded in this model of severe fetal glucocorticoid deficiency, and
that structural components of the SC, such as loricrin, involucrin, and
filaggrin, as well as lipid synthetic enzymes such as β-glucocerebrosidase
and steroid sulfatase, are reduced, thus demonstrating a physiologic
role for glucocorticoids in the maturation of the epidermis and SC.
MATERIALS AND METHODS
Animals and initial skin preparation A colony of mice homozygous for
null CRH alleles was obtained by targeted mutation in embryonic stem cells
followed by matings of heterozygotes bearing a copy of the null CRH allele
(Muglia et al, 1995). Both controls and null CRH mice were from the same
mixed C57Bl/6 3 129 background. Homozygotes of heterozygous matings are
viable and fertile, but exhibit no detectable CRH mRNA or protein; cortico-
steroid levels are virtually undetectable in males and are markedly reduced in
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females. Homozygous CRH-deficient females and males were separated after
mating (positive vaginal plug 5 day 1 of pregnancy; term is 19–20 d). In
some experiments, pregnant animals beginning at day 12 of gestation were
supplemented with corticosteroid in the drinking water (30 µg per ml) to
achieve physiologic replacement (Jacobson et al, 1989). Skin samples, obtained
in Boston from several different litters in each treatment group and coded,
underwent initial processing prior to shipment to San Francisco, where they
were further processed and examined without knowledge of the specific
gestational age or treatment.
Light microscopy Sections (0.5 µm) of skin from the back and lateral
abdominal wall were fixed in modified Karnovsky’s fixative (0.1 M sodium
cacodylate buffer containing 2% glutaraldehyde, 2% paraformaldehyde, and
0.06% CaCl2, pH 7.3), epon-embedded, and stained with toluidine blue for
light microscopy. Parallel samples were frozen in OCT compound and stored
at –70°C (Miles Scientific, Naperville, IL). Nile red was applied to 5 µm frozen
sections and examined with a Leitz microscope equipped for epifluorescence
(excitation 489, emission 515) (Grubauer et al, 1989).
Electron microscopy Skin samples obtained from several different litters of
each treatment group were minced to 1 mm3 fragments, fixed in modified
Karnovsky’s fixative, and postfixed in reduced 1% osmium or buffered 0.2%
ruthenium tetroxide with 0.5% ferrocyanide (Aszterbaum et al, 1992), then
dehydrated in graded ethanol, embedded in Epon, and sectioned. Sections were
examined using a Zeiss electron microscope at 60 kV.
In situ hybridization Digoxigenin-labeled RNA probes to detect loricrin
and filaggrin were made from linearized cDNA sequences as templates (a gift
from S. Yuspa, NIH), using reagent supplied by Boehringer (Indianapolis, IN).
In situ hybridization was performed as described previously (Stelnicki et al,
1998), with probes applied to the sections and hybridized at 55°C for loricrin
or 40°C for filaggrin. The hybridization of DIG-labeled probes to the
endogenous mRNA was revealed by alkaline phosphatase reaction, using BCIP/
NTBT substrate. The sections were counterstained with Methyl Green and
coverslipped. Probes of sense orientation served as controls to ensure the
specificity of mRNA detection. A set of controls was used to establish the
specificity of the hybridization. Omitting the DIG-labeled probes resulted in
no signal, indicating that only DIG-containing RNA hybrids were detected.
The sense control probes resulted in no signal, indicating the specificity of
hybridization with the anti-sense probe (not shown).
Immunohistochemistry Rabbit anti-peptide antibodies (BabCo, Berkeley,
CA) specific for mouse involucrin and loricrin were used. The binding of these
antibodies to the sections were detected by affinity-purified, biotinylated goat
anti-rabbit IgG, followed by ABC-alkaline phosphatase reagent, both purchased
from Vector (Burlingame, CA). Alkaline phosphastase activity was revealed
using BCIP/NTNB as substrate, followed by a nuclear counterstaining with
Methyl Green. Omitting the first antibodies resulted in no signal.
Enzyme assays β-glucocerebrosidase activity was measured as described
previously (Hanley et al, 1997b). Briefly, whole skin was excised from day 17.5
fetal animals and stored at –70°C. On the day of the assay, tissues were thawed
on ice and homogenized (10% wt/vol) in phosphate-buffered saline containing
0.1 mM phenylmethylsulfonyl fluoride and 0.1% Tween 20. Following a 30 min
incubation on ice, homogenates were centrifuged at 10,0003g for 10 min
(4°C). Fifty microliters of the resultant supernatant was added to an equal
volume of reaction buffer (5 mM sodium taurocholate with 0.5 mM 4-MUG
in citrate-phosphate buffer, pH 5.6) and incubated for 60 min at 37°C. The
reaction was terminated with 2 ml of pH 10.5 carbonate-bicarbonate buffer,
and fluorescence was measured at 360 λ (emission) and 450 λ (excitation).
Steroid sulfatase was assayed in microsomal preparations as previously described
(Hanley et al, 1997c). Assays were performed in 0.1 M Tris-HCl, pH 7.4, with
5.6 mM glucose and 15 µM (5 µCi) [3H]DHEAS for 2 h at 37°C. Following
extraction with benzene, product ([3H]DHEA) was quantitated by scintillation
spectroscopy.
Statistics Data are presented as mean 6 SEM. Statistical significance was
determined by a Student’s t test.
RESULTS
SC membrane formation is delayed in glucocorticoid deficient
(C-) fetal mice To begin to determine the role of glucocorticoid
deficiency during SC ontogenesis, we examined the architecture of the
upper epidermis in control fetal mice [wild-type (WT) 5 CRH 1/?]
and in fetal mice obtained through matings of mice homozygous for
Figure 1. Formation of a multilayered stratum granulosum and SC is
delayed in C-pups at 17.5 d, but is corrected by maternal glucocorticoid
replacement, and is normal by term. Representative light microscopic
sections of fetal mouse skin. (A) WT, 17.5d; (B) CRH-null, 17.5 d; (C) CRH-
null with maternal glucocorticoid replacement, 17.5 d; (D) WT, term; (E)
CRH-null, term. WT, wild-type; C-, CRH-null; C-Rx, CRH-null with
glucocorticoid replacement; T, term. Arrowheads, thin SC in 17.5 d pups; open
arrows, multilayered SC in term animals; closed arrow, periderm; brackets, combined
stratum granulosum/SC thickness. Scale bar: 15 µm.
CRH-null alleles (C-). As shown in Fig 1(A), light microscopic
sections of epidermis from WT mice of gestational age day 17.5
exhibited a distinct granular layer (brackets) and thin SC (arrowheads).
Moreover, electron microscopy typically showed 2–3 layers of cornified
cells in WT day 17.5 epidermis (Fig 2A). Skin sections were also
stained with the lipid probe Nile red, which detects polar lipids as red-
orange fluorescence and neutral lipids as yellow-gold. WT epidermis
(day 17.5) showed a mature, membrane pattern of staining in the upper
epidermis (arrows), with localized areas of yellow-gold fluorescence in
the SC (Fig 3A). The lipid membranes were further evaluated using
ruthenium tetroxide postfixation and electron microscopy. Lamellar
body-secreted material that had not been reorganized into mature
lamellae was abundant in the interface between the stratum granulosum
and the SC, and mature lamellar unit structures were continuous
throughout the extracellular spaces of the SC (Fig 4A).
In contrast to WT epidermis on day 17.5, neither a well-defined
granular layer nor a SC was evident in light microscopic sections of
skin from C-pups of the same gestational age (Fig 1B). Moreover,
electron microscopy revealed either no SC or at most a single layer of
SC in the C-mice (Fig 2B). Nile red staining was red-orange, indicative
of polar lipid, and was distributed in a predominantly cytosolic pattern,
with very little membrane pattern staining (Fig 3B). Ultrastructurally,
lamellar body-derived material was abundant in the outer cellular
interspaces, but was not yet organized into lamellar unit structures in
C-pups that had no cornified cells (Fig 4B); whereas, in those C-pups
who exhibited a single cornified cell layer, mature lamellae were
present only in focal areas (Fig 4C). Thus, the formation of a
multilayered SC with a membrane pattern of neutral lipid deposition
and the reorganization of secreted lamellar material into mature lamellar
unit structures within the SC, is delayed in glucocorticoid-deficient
fetal mice.
Loricrin, filaggrin, and involucrin expression is reduced in
C-fetal mice To determine whether the delay in SC formation in
C-pups was accompanied by a delay in the expression of structural
proteins necessary for cornified envelope formation, we first used in
situ hybridization to examine the expression of loricrin and filaggrin.
As shown in Fig 5, expression of both loricrin and filaggrin mRNA
was decreased in C-pups (Fig 5A, C) compared with WT (Fig 5B,
D) on day 17.5. Furthermore, protein levels of loricrin, as well as
involucrin, an earlier marker of differentiation, detected by immuno-
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Figure 2. SC thickness is reduced in C-
pups at 17.5 d. Low magnification electron
microscopic sections of fetal mouse skin. (A)
WT; (B) CRH-null (C-). Arrows, periderm (P).
Reduced osmium fixation. Scale bar: 1 µm.
cytochemistry, were also decreased in C-pups compared with WT on
day 17.5 (Fig 5E–H). Thus, mRNA and protein levels of several
different protein markers of epidermal differentiation are diminished
in glucocorticoid-deficient fetal mice.
b-glucocerebrosidase and steroid sulfatase activity is inhibited
in C-fetal mice The SC is comprised of both protein and lipid
constituents, and we have shown previously that the lipid synthetic
enzymes β-glucocerebrosidase and steroid sulfatase increase during SC
and epidermal barrier development in utero (Hanley et al, 1997b, c).
As shown in Fig 6, the activity of β-glucocerebrosidase, which converts
glucosylceramide to ceramide, as well as steroid sulfatase, which
desulfates cholesterol sulfate in the SC, are decreased in C-pups on
day 17.5 compared with WT pups of the same age. These data
indicate that the formation of the lipid enzyme markers of epidermal
differentiation are inhibited in glucocorticoid-deficient fetal mice.
Maternal glucocorticoid replacement normalizes SC develop-
ment in C-fetal mice To determine the effects of glucocorticoid
replacement on C-fetal mouse epidermis, maternal C-mice were given
physiologic amounts of corticosteroid in their drinking water starting
on day 12, and fetal epidermis was examined on day 17.5. As shown
in Fig 1(C), a distinct stratum granulosum (brackets) and thin SC
(arrowhead), similar to WT epidermis (Fig 1A), was evident by light
microscopy. Nile red histochemistry revealed a membrane pattern of
staining in the uppermost epidermis (arrows) (Fig 3C), also similar to
WT animals (Fig 3A). Finally, the extracellular spaces of the SC were
filled with mature lamellar bilayer unit structures by electron microscopy
(Fig 4D). Thus, glucocorticoid replacement starting on day 12 normal-
izes SC formation in C-fetal mice.
A mature SC forms by full term in C-mice At term, both WT
and C-neonates exhibited a multilayered SC (Fig 1D, E, respectively,
arrows), with a mature pattern of yellow-gold fluorescence, using Nile
red histochemistry (Fig 3D, E, respectively). Moreover, by electron
microscopy the extracellular spaces of the SC in both WT (not shown)
and C- (Fig 4E) mice were replete with mature lamellar unit structures.
Thus, by term the SC was morphologically indistinguishable in C-
and WT mice, suggesting either that corticosteroid is not absolutely
required for SC maturation, or that the low level of glucocorticoid
present in C-fetal mice is sufficient for maturation.
DISCUSSION
Administration of glucocorticoids to the developing fetus has been
shown to accelerate maturation of a number of organ systems, including
lung (Mendelson and Boggaram, 1991), gastrointestinal tract (Stalmans
et al, 1987), kidney (Djouadi et al, 1996), and brain (Trejo et al,
1995), as well as to accelerate formation of a competent barrier to
transepidermal water loss in epidermis (Aszterbaum et al, 1992; Hanley
et al, 1996a). Glucocorticoid action has been most extensively studied
in lung, where it has been found to regulate genomic expression of
enzymes of surfactant lipid synthesis (Gonzales et al, 1994) and of
surfactant apoproteins (Xu et al, 1995; Ballard et al, 1996; Dulkerian
et al, 1996). Until recently, however, the role of endogenous, i.e.,
physiologic, levels of corticosteroids in normal fetal development was
Figure 3. SC neutral lipid deposition is delayed in C-pups at 17.5 d,
but is corrected by maternal glucocorticoid replacement, and is normal
by term. Representative Nile red fluorescent microscopic sections of fetal
mouse skin. (A) WT, 17.5d; (B) CRH-null, 17.5 d; (C) CRH-null with
maternal glucocorticoid replacement, 17.5 d; (D) WT, term; (E) CRH-null,
term. WT, wild-type; C-, CRH-null; C-Rx, CRH-null with glucocorticoid
replacement; T, term. Arrows, lipid deposition in outer stratum granulosum and
SC. Polar lipids fluoresce red-orange, neutral lipids fluoresce yellow-gold. Scale
bar: (A, B, C) 8 µm; (D, E) 5.5 µm.
unclear. The development of a transgenic model of severe corticosteroid
deficiency, in which both mothers and pups are homozygous for null-
CRH alleles, has permitted evaluation of the impact of profound
corticosteroid deficiency on organ maturation (Muglia et al, 1995).
Despite their normal gross appearance at birth, the C-pups all die
within the first 12 h of life, with morphologically immature lungs and
markedly reduced surfactant apoprotein mRNA expression (Muglia
et al, 1995). Maternal replacement with physiologic amounts of
corticosteroids normalizes fetal lung maturation and restores postnatal
viability. These data demonstrated an essential role for corticosteroids
in normal lung maturation.
Using this same transgenic model, we now demonstrate that physio-
logic levels of corticosteroids also regulate maturation of the SC
membrane system in epidermis. Although we were unable to directly
assess barrier function in these pups, previous studies from this laboratory
have demonstrated that formation of a competent barrier in the fetal
rodent is invariably accompanied by formation of a mature SC
architecture; namely, by the deposition of neutral lipid in the intercellu-
lar domains of the SC, as visualized at the light microscopic level using
the hydrophobic dye, Nile red, and by the organization of this lipid
into mature lamellar unit structures, as visualized using ruthenium
tetroxide postfixation, ultrastructurally (Aszterbaum et al, 1992, 1993;
Williams et al, 1993; Holleran et al, 1994; Hanley et al, 1996a, b).
Loricrin and filaggrin are important structural components of the
skin, and their expression in the granular layer increases co-ordinately
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Figure 4. Formation of mature SC lamellar
unit structures is retarded in C-pups at
17.5 d, but is corrected by maternal
glucocorticoid replacement, and is normal
by term. Representative electron micrographs
of ruthenium tetroxide postfixed thin sections.
(A) SC, WT, 17.5d; (B) unprocessed lamellar
body derived contents (open arrows), CRH-null,
17.5 d; (C) SC, CRH-null, 17.5 d; (D) SC,
CRH-null with maternal glucocorticoid
replacement, 17.5 d; (E) SC, CRH-null, term.
WT, wild-type; C-, CRH-null; C-Rx, CRH-
null with glucocorticoid replacement; T, term.
Solid arrows, lamellar membranes; open arrows,
unprocessed lamellar body derived material.
Scale bar: 0.5 µm.
Figure 5. Diminished expression of
loricrin, filaggrin, and involucrin on day
17.5 in C-mice (A, C, E, G) compared
with WT (B, D, F, H). Loricrin and filaggrin
mRNA (A–D) was detected by in situ
hybridization and loricrin and involucrin pro-
tein (E–H) was detected by immunohisto-
chemistry, as described in Materials and Methods.
Scale bar: 50 µm.
with the appearance and secretion of lamellar bodies during fetal
epidermal development (Bickenbach et al, 1995). The expression of
these proteins, as well as of involucrin, an earlier marker of differenti-
ation, is reduced in C-day 17.5 pups. Furthermore, the activity of two
lipid enzyme markers of barrier maturation, β-glucocerebrosidase and
steroid sulfatase, are decreased in C-pups. These results demonstrate
coordinate regulation of both lipid enzymes and structural proteins.
The mechanism by which glucocorticoids regulate the lipid and
structural protein components of the SC requires further study.
Additionally, it remains to be determined whether glucocorticoids
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Figure 6. Decreased activity of b-glucocerebrosidase and steroid
sulfatase in epidermis of C-day 17.5 mice. Activity was measured as
described in Materials and Methods. WT, wild-type; C-, CRH null. Data are
expressed as mean 6 SEM. *p ø 0.01; **p ø 0.02.
regulate epidermal differentiation via direct effects on the skin or by
altering the production of other factors produced in other tissues,
either fetal or maternal. We have in previous studies shown that
glucocorticoids accelerate barrier formation in full-thickness fetal skin
explants (Hanley et al, 1996a), which, taken together with studies by
others showing induction of keratinocyte differentiation by gluco-
corticoids (Monzon et al, 1996), suggests direct effects upon fetal
epidermis.
The SC and the lung exhibit several similarities. Both mature
following the same developmental timetable, and the maturation of
both systems is accelerated by hormones such as glucocorticoids,
thyroid hormone, and estrogens. Additionally, both tissue systems rely
on secretory organelles, lamellar bodies, to deliver lipids to an air/
tissue interface. An important difference between lung and skin
maturation is evident from this study, however; namely, that SC
maturation is delayed, but not prevented, by glucocorticoid deficiency.
Thus, at term, lung development in C-pups remains immature and
probably accounts for their neonatal demise, and in contrast the SC is
morphologically mature. Hence, glucocorticoids exhibit a modifying
role in fetal barrier formation, accelerating its formation when given
in excess, and retarding its formation when insufficient levels are
present. As in lung, glucocorticoids are likely to modulate epidermal
maturation through regulation at the genomic level. Glucocorticoids
regulate involucrin gene expression in human keratinocytes (Monzon
et al, 1996), and we have shown that in fetal epidermis glucocorticoids
increase the activities of β-glucocerebrosidase and steroid sulfatase
(Hanley et al, 1997b, c), enzymes that are essential for normal SC
function (Williams, 1991; Holleran et al, 1993).
We have recently also had the opportunity to examine the role of
thyroid hormone in normal barrier ontogenesis using a homozygous
TSH receptor knock-out transgenic model (Hanley et al, 1997a).
Thyroid hormone exerts a similar modifying role in epidermal develop-
ment, in that SC membrane maturation is delayed, but not prevented,
by severe fetal thyroid hormone deficiency. It is likely that multiple
factors regulate the development of the SC, such that the absence of
any single factor delays but ultimately is not absolutely essential for its
formation.
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